Analysis and stability study of temozolomide using capillary electrophoresis
Authors:
- Rose BustosRBRose Bustos
- Attila GasparAGAttila Gaspar
- Frank A. GomezFGFrank A. Gomez
- Almos KleknerAKAlmos Klekner
- 1 July 2010
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 878 (21) , 1801-1808
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Evaluation of the exposure equivalence of oral versus intravenous temozolomideCancer Chemotherapy and Pharmacology, 2009
- Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgeryJournal of Neuro-Oncology, 2009
- Plasma and Cerebrospinal Fluid Pharmacokinetics of Intravenous Temozolomide in Non-human PrimatesJournal of Neuro-Oncology, 2003
- TemozolomideAmerican Journal of Cancer, 2002
- High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2001
- An LC/MS/MS method for the quantitation of MTIC (5-(3-N-methyltriazen-1-yl)-imidazole-4-carboxamide), a bioconversion product of temozolomide, in rat and dog plasmaJournal of Pharmaceutical and Biomedical Analysis, 1999
- High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and Its Interaction with DNABiochemistry, 1994
- Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamideCancer Chemotherapy and Pharmacology, 1991